Stocks To Buy Now

Blog


Summit Recap: 8th Digital Strategy & Innovation for Medical Affairs

The 8th Digital Strategy & Innovation for Medical Affairs Summit took place on June 5-6, 2024, in Philadelphia. This event brought together professionals from pharmaceutical, biotechnology, and medical device sectors to explore the latest digital engagement strategies and innovations in medical affairs. Key topics included leveraging AI to improve patient outreach, tracking the patient journey with digital technologies, and developing effective digital engagement strategies.

The summit featured expert presentations, panel discussions, and interactive workshops, allowing attendees to gain insights into best practices and emerging trends. Participants had the opportunity to network with industry leaders and peers, fostering collaborations and sharing experiences on how to navigate the rapidly evolving digital landscape in medical affairs. The speaking faculty joined from various organizations, including AstraZeneca, Bayer, Pfizer, and Takeda.

For those unable to attend the event in person, an On-Demand option is available, enabling participants to watch the summit sessions at their convenience from anywhere. This ensures that the valuable knowledge and insights shared during the summit are accessible to a broader audience.

Learn more: https://dgevents.com/event/8th-digital_strategy-innovation-for-medical-affairs-summit/

From Our Blog

ParaZero Technologies Ltd. (NASDAQ: PRZO) Is ‘One to Watch’

January 8, 2026

ParaZero Technologies (NASDAQ: PRZO) is a defense aerospace company specializing in multi-layered Counter-Unmanned Aircraft System (“Counter-UAS”) technologies engineered to neutralize hostile drones in complex, contested, and urban environments. Founded by aviation and defense technology professionals, the company develops autonomous interception and precision-delivery systems that support military forces, homeland security agencies, and operators of strategic infrastructure. […]

Rotate your device 90° to view site.